secwatch.observer — SEC 8-K summary
======================================

Issuer:     PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)
CIK:        0001552189
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001493152-24-009173
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Panacea Life Sciences issues 666K shares to settle $100K note payment
---------------------------------------------------------------------

- Converted $100,000 note payment to 666,000 shares of common stock on March 5, 2024.
- Previous conversion in Feb 2023: 540,000 shares at $0.25/sh partially repaid the $385K note.
- Original $385K Senior Convertible Note issued Mar 2022 in exchange for 350 Series A Preferred shares.
- Company could not fund $100K cash payment due June 30, 2023; settled via stock conversion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1552189/000149315224009173/0001493152-24-009173-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1552189/000149315224009173/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009173

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer